US Surgical buys Pfizer's Valleylab for $425 million
This article was originally published in Clinica
Pfizer is to sell its Valleylab electrosurgical and ultrasonics business to US Surgical for $425 million in cash. USS has been aggressively acquiring companies over the past few months, but this is by far the largest cash expenditure on buying new business.
You may also be interested in...
Per- and polyfluoroalkyl substances (PFAS) are under increasing scrutiny in the US and Europe. Stakeholders have until 31 July to submit information to the authorities of five European countries as they prepare a joint proposal for a broad PFAS restriction under the bloc’s REACH regulation.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.